后COVID肺部后果:减少持久性纤维化的机制和潜在目标
Emma C A Vreeman1, Janesh Pillay2, Janette K Burgess3
1University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.
Pharmacology & therapeutics
|May 30, 2025
概括
后急性COVID-19 (PASC) 或长期COVID的后果可能导致持续性肺纤维化. 研究表明可能会造成长期的肺损伤,并强调需要有效的抗纤维化疗法.
科学领域:
- 肺部医学 肺部医学
- 病毒学 病毒学
- 病理学 病理学 病理学
背景情况:
- COVID-19大流行导致长期健康问题的出现,包括COVID-19 (PASC) 后急性后果,通常称为长期COVID.
- 感染SARS-CoV-2的个体中有很大一部分经历了PASC,肺部是主要目标,往往导致纤维化病变和呼吸功能减弱.
研究的目的:
- 调查COVID-19后肺纤维化的流行,持续性和潜在的治疗点.
- 将当前的发现与类似病毒感染的历史数据进行比较,以了解长期的肺部病变.
主要方法:
- 关于PASC和COVID-19后肺纤维化目前文献的综述.
- 对之前的SARS-CoV感染 (2003年) 的数据进行分析,以评估长期肺功能障碍.
- 确定抗纤维菌治疗的潜在药理目标.
主要成果:
- 包括肺部功能障碍在内的PASC症状在感染后可能持续长达3年.
- 肺部损伤类似于2003年SARS-CoV感染后出现的肺部损伤,可能持续超过15年.
- 现有的抗纤维治疗方法 (皮尔费尼,尼丁达尼布) 和新兴疗法 (HDAC 抑制剂,ARB,MSC) 是有前途的.
结论:
- 感染SARS-CoV-2携带长期肺纤维化潜在风险,构成严重的公共卫生问题.
- 进一步的研究对于阐明持久性肺纤维化机制和确定有效的治疗策略至关重要.
- 开发新的抗纤维性治疗方法对于管理和潜在地逆转COVID-19后的肺纤维化至关重要.
更多相关视频
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20COPD: Pathogenesis and Clinical Features
244
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
244
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:24Cystic Fibrosis: Management
146
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
146
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K